| Product Code: ETC9409657 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Korea Oncology Molecular Diagnostic Market Overview |
3.1 South Korea Country Macro Economic Indicators |
3.2 South Korea Oncology Molecular Diagnostic Market Revenues & Volume, 2021 & 2031F |
3.3 South Korea Oncology Molecular Diagnostic Market - Industry Life Cycle |
3.4 South Korea Oncology Molecular Diagnostic Market - Porter's Five Forces |
3.5 South Korea Oncology Molecular Diagnostic Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 South Korea Oncology Molecular Diagnostic Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 South Korea Oncology Molecular Diagnostic Market Revenues & Volume Share, By Test Location, 2021 & 2031F |
3.8 South Korea Oncology Molecular Diagnostic Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.9 South Korea Oncology Molecular Diagnostic Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 South Korea Oncology Molecular Diagnostic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in South Korea |
4.2.2 Growing demand for personalized medicine and targeted therapies |
4.2.3 Technological advancements in molecular diagnostics |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for molecular diagnostic tests |
4.3.2 High cost associated with molecular diagnostic tests |
4.3.3 Limited access to advanced healthcare facilities in rural areas |
5 South Korea Oncology Molecular Diagnostic Market Trends |
6 South Korea Oncology Molecular Diagnostic Market, By Types |
6.1 South Korea Oncology Molecular Diagnostic Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 South Korea Oncology Molecular Diagnostic Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 South Korea Oncology Molecular Diagnostic Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.1.4 South Korea Oncology Molecular Diagnostic Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.1.5 South Korea Oncology Molecular Diagnostic Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.1.6 South Korea Oncology Molecular Diagnostic Market Revenues & Volume, By Cervical Cancer, 2021- 2031F |
6.1.7 South Korea Oncology Molecular Diagnostic Market Revenues & Volume, By Liver Cancer, 2021- 2031F |
6.1.8 South Korea Oncology Molecular Diagnostic Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.1.9 South Korea Oncology Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 South Korea Oncology Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
6.2 South Korea Oncology Molecular Diagnostic Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 South Korea Oncology Molecular Diagnostic Market Revenues & Volume, By Instruments, 2021- 2031F |
6.2.3 South Korea Oncology Molecular Diagnostic Market Revenues & Volume, By Reagents, 2021- 2031F |
6.2.4 South Korea Oncology Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
6.3 South Korea Oncology Molecular Diagnostic Market, By Test Location |
6.3.1 Overview and Analysis |
6.3.2 South Korea Oncology Molecular Diagnostic Market Revenues & Volume, By Clinics, 2021- 2031F |
6.3.3 South Korea Oncology Molecular Diagnostic Market Revenues & Volume, By Other Establishments, 2021- 2031F |
6.3.4 South Korea Oncology Molecular Diagnostic Market Revenues & Volume, By Point of Care, 2021- 2031F |
6.4 South Korea Oncology Molecular Diagnostic Market, By Technology |
6.4.1 Overview and Analysis |
6.4.2 South Korea Oncology Molecular Diagnostic Market Revenues & Volume, By PCR, 2021- 2031F |
6.4.3 South Korea Oncology Molecular Diagnostic Market Revenues & Volume, By Multiplex, 2021- 2031F |
6.4.4 South Korea Oncology Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
6.4.5 South Korea Oncology Molecular Diagnostic Market Revenues & Volume, By In Situ Hybridization, 2021- 2031F |
6.4.6 South Korea Oncology Molecular Diagnostic Market Revenues & Volume, By Isothermal Nucleic Acid Amplification Technology (INAAT), 2021- 2031F |
6.4.7 South Korea Oncology Molecular Diagnostic Market Revenues & Volume, By Chips and Microarrays, 2021- 2031F |
6.4.8 South Korea Oncology Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
6.4.9 South Korea Oncology Molecular Diagnostic Market Revenues & Volume, By Others, 2021- 2031F |
6.5 South Korea Oncology Molecular Diagnostic Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 South Korea Oncology Molecular Diagnostic Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 South Korea Oncology Molecular Diagnostic Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
7 South Korea Oncology Molecular Diagnostic Market Import-Export Trade Statistics |
7.1 South Korea Oncology Molecular Diagnostic Market Export to Major Countries |
7.2 South Korea Oncology Molecular Diagnostic Market Imports from Major Countries |
8 South Korea Oncology Molecular Diagnostic Market Key Performance Indicators |
8.1 Adoption rate of molecular diagnostic tests in oncology |
8.2 Investment in research and development for new diagnostic technologies |
8.3 Number of partnerships and collaborations between diagnostic companies and healthcare providers |
8.4 Rate of reimbursement for molecular diagnostic tests by healthcare insurance providers |
8.5 Patient outcomes and survival rates following molecular diagnostic-guided treatment |
9 South Korea Oncology Molecular Diagnostic Market - Opportunity Assessment |
9.1 South Korea Oncology Molecular Diagnostic Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 South Korea Oncology Molecular Diagnostic Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 South Korea Oncology Molecular Diagnostic Market Opportunity Assessment, By Test Location, 2021 & 2031F |
9.4 South Korea Oncology Molecular Diagnostic Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.5 South Korea Oncology Molecular Diagnostic Market Opportunity Assessment, By End User, 2021 & 2031F |
10 South Korea Oncology Molecular Diagnostic Market - Competitive Landscape |
10.1 South Korea Oncology Molecular Diagnostic Market Revenue Share, By Companies, 2024 |
10.2 South Korea Oncology Molecular Diagnostic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here